During the past decade, North Bay Eye Associates, Inc. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 15 clinical trials were completed, i.e. on average, 93.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 12 clinical trials were completed. i.e. 240% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Bay Eye Associates, Inc." #1 sponsor was "Allergan" with 4 trials, followed by "Santen Inc." with 4 trials sponsored, "Aerie Pharmaceuticals" with 2 trials sponsored, "Glaukos Corporation" with 2 trials sponsored and "Kala Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Bay Eye Associates, Inc." #1 collaborator was "CBCC Global Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "North Bay Eye Associates, Inc." are "Ocular Hypertension" (6 trials), "Glaucoma, Open-Angle" (3 trials), "Glaucoma and Ocular Hypertension" (2 trials), "Keratoconjunctivitis Sicca" (2 trials) and "Open-Angle Glaucoma" (2 trials). Many other conditions were trialed in "North Bay Eye Associates, Inc." in a lesser frequency.

Most popular intervention types in "North Bay Eye Associates, Inc." are "Drug" (22 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "DE-117 Ophthalmic Solution" (2 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials) and "Timolol Maleate Ophthalmic Solution 0.5%" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Bay Eye Associates, Inc." are 23 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "North Bay Eye Associates, Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in North Bay Eye Associates, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in North Bay Eye Associates, Inc., 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".